Recorded fact · drug.label_indication
drug.label_indication for linagliptin|type-2-diabetes
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 0b871f10 resolves to.
The record
| Fact id | 0b871f109a8ad70fd889fcf3 |
|---|---|
| Entity | drug: linagliptin|type-2-diabetes |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20240122 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus .
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 2e508f7171c85cb4f9fe0c410c8536cc7f8173c2cd37297b40b641ef33ad6532.
The value
{
"ingredient": "LINAGLIPTIN",
"conditionId": "type-2-diabetes",
"conditionName": "Type 2 diabetes",
"matchedAlias": "type 2 diabetes",
"context": "indication",
"brand": "Tradjenta",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "b1da67d4-51e0-41b7-9fe1-7f38c0d1baa1",
"labelEffectiveTime": "20240122",
"labelsRead": 3,
"labelsNaming": 3,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: c8fa8ff1eac587afa99a29fa80e69825ff3c936f10c09b49362b0b6077adec35.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.